FAFGX | MSEGX | FAFGX / MSEGX | |
Total Expense Ratio | 0.40 | 0.82 | 49% |
Annual Report Gross Expense Ratio | 0.40 | 0.82 | 49% |
Fund Existence | 5 years | 29 years | - |
Gain YTD | -2.355 | -1.735 | 136% |
Front Load | N/A | 5% | - |
Min. Initial Investment | 250 | 1000 | 25% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 284B | 3.77B | 7,533% |
Annual Yield % from dividends | 0.61 | 0.43 | 142% |
Returns for 1 year | 3.90 | 41.82 | 9% |
Returns for 3 years | 35.68 | 42.96 | 83% |
Returns for 5 years | N/A | -11.27 | - |
Returns for 10 years | N/A | 20.27 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BIAWX | 50.05 | N/A | N/A |
Brown Advisory Sustainable Growth Inv | |||
VNVNX | 22.15 | N/A | N/A |
Natixis Vaughan Nelson Mid Cap N | |||
FBTDX | 96.52 | N/A | N/A |
Franklin Biotechnology Discovery C | |||
LCFLX | 12.88 | N/A | N/A |
Lord Abbett Focused Large Cap Value C | |||
CDWEX | 11.44 | -0.02 | -0.17% |
American Funds Dvlpg Wld Gr&Inc 529E |